Aeterna Zentaris to Present at Upcoming Canaccord Genuity 34th Annual Global Growth Conference in Boston

Aug 06, 2014, 07:30 ET from Aeterna Zentaris Inc.

QUÉBEC CITY, Aug. 6, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Chairman, CEO, David Dodd, will be presenting a corporate overview at the Canaccord Genuity 34th Annual Global Growth Conference on Wednesday, August 13, 2014, at 1pm (Eastern), in the Melbourne Room of the Intercontinental Hotel in Boston.

A live audio and slide webcast of the presentation will be available via the Company's website at in the "Newsroom" section, under "Events and Webcasts". A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds at various stages of development. For more information, visit

SOURCE Aeterna Zentaris Inc.